A new £35 million oncology centre is to be built in Liverpool.

Proton Partners International Ltd has awarded an £11.5 million contract to Interserve to build the facility, which will be known as the Rutherford Cancer Centre North West.

The centre will bring the advanced treatments in cancer care to the region, including high energy proton beam therapy, as well as the latest technology on the market to deliver radiotherapy, chemotherapy, imaging and diagnostics.


Work is scheduled to start on site on 08 January 2018. Conventional treatments will be available from 2018 and high-energy proton beam therapy will be available from 2019.

Phil Shaw, Interserve's construction director for the North West, said: "The team's knowledge, experience, innovation and expertise contributed to winning this contract. We are delighted to be embarking on a journey with Proton Partners International to jointly deliver a successful project."

Mike Moran, Chief Executive Officer of Proton Partners International, said: "We are really pleased to announce that we have appointed Interserve, one of the world's foremost support services and construction companies, as our partners. We are confident that their team will provide the very best quality and expertise in building our Rutherford Cancer Centre in Liverpool."

(LM)